Condition: Rhinosinusitis · Rhinosinusitis Acute · Sponsor: Materia Medica Holding
Multicenter double-blind placebo-controlled randomized in parallel groups clinical trial of the efficacy and safety of Raphamin in the treatment of acute rhinosinusitis in adult patients.
This description comes directly from the study's public registry record.
Mikhail Putilovskiy, MD,PhD · +74952761571 · PutilovskiyMA@materiamedica.ru
Always discuss trial participation with your own doctor first.
| Aramil city hospital | Aramil, Russia | Active Not Recruiting |
| Gatchina Clinical Interdistrict Hospital | Gatchina, Russia | Completed |
| Baltic Federal University named after Immanuel Kant | Kaliningrad, Russia | Recruiting |
| Kazan State Medical University/Department of Infectious Diseases | Kazan', Russia | Completed |
| Kuban State Medical University/Department of Infectious Diseases and Phthisiopulmonology | Krasnodar, Russia | Terminated |
| City Polyclinic # 2 of the Moscow City Department of Health | Moscow, Russia | Recruiting |
| First Moscow State Medical University named after I.M. Sechenov/Department of Ear, Nose and Throat Diseases | Moscow, Russia | Completed |
| National Medical Research Center of Otolaryngology | Moscow, Russia | Recruiting |
| Russian University of Medicine/Department of Otolaryngology | Moscow, Russia | Completed |
| Moscow Regional Research Clinical Institute named after M.F. Vladimirsky | Moscow, Russia | Active Not Recruiting |
| LLC "Persona Group of Companies" | Nizhny Novgorod, Russia | Completed |
| Novosibirsk State Medical University/Department of Otolaryngology | Novosibirsk, Russia | Completed |
+ 32 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06901297